SENP Proteases as Potential Targets for Cancer Therapy
SUMOylation is a reversible post-translational modification (PTM) involving a covalent attachment of small ubiquitin-related modifier (SUMO) proteins to substrate proteins. SUMO-specific proteases (SENPs) are cysteine proteases with isopeptidase activity facilitating the de-conjugation of SUMO prote...
Main Authors: | Paulina Tokarz, Katarzyna Woźniak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2059 |
Similar Items
-
SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation
by: Tingting Liu, et al.
Published: (2023-09-01) -
Emerging role of SENP1 in tumorigenesis and cancer therapy
by: Min Lin, et al.
Published: (2024-02-01) -
Revised annotation and extended characterizations of components of the Chlamydomonas reinhardtii SUMOylation system
by: Yen‐Ling Lin, et al.
Published: (2020-09-01) -
Sumoylation in synaptic function and dysfunction
by: Lenka eSCHOROVA, et al.
Published: (2016-04-01) -
Advances in the development of SUMO specific protease (SENP) inhibitors
by: Ashutosh Kumar, et al.
Published: (2015-01-01)